Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine
DeviceTalks Podcast Network
Hear why Merck KGaA and INBRAIN Neurolectronics see such great promise in Bioelectronic medicine

Jul 23 2021 | 00:42:16

/
Episode • July 23, 2021 • 00:42:16

Hosted By

Kayleen Brown Tom Salemi

Show Notes

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential. Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation. Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Previous Episode

Hear from the CEOs of two surgical robotics companies that together just raised over $1 billion

Next Episode

What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Other Episodes

June 06, 2013

Why healthy patients die in the hospital with Johns Hopkins patient safety expert Peter Pronovost

Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.

Play

00:09:08

December 22, 2023

It’s the Big One! Hear our Media Roundtable Debate and Discuss the Top Medtech Newsmakers of 2023

In our final DeviceTalks Weekly of the year, the news team assembles to highlight MassDevice’s Top Medtech Trends of 2023. Let us know if...

Play

00:55:53

December 16, 2022

How ReCor Medical is building a strong clinical case for renal denervation; let your voice be heard

In this episode, we’ll speak with ReCor Medical’s CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company’s vice president of clinical affairs. The pair...

Play

00:43:49